Skip to main content
OpenTrials

Clinical trial condition

Metastatic Gastric Carcinoma

Explore clinical trials studying Metastatic Gastric Carcinoma. Study availability and eligibility vary by location and protocol.

13 public trials 5 recruiting studies
Refine in advanced search Browse all conditions

Metastatic Gastric Carcinoma trial results

Active, not recruiting

A Study of agenT-797 in Combination With Botensilimab, Balstilimab, Ramucirumab, and Paclitaxel for People With Esophageal, Gastric, or Gastro-esophageal Junction Cancer

NCT06251973

Conditions
Adenocarcinoma Of Esophagus, Advanced Unresectable Gastric Adenocarcinoma, Digestive System Diseases, +22 more
Locations
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Suffolk-Commack (Limited protocol activities) Commack, New York, United States
View Trial Details
Completed

Olaparib and Ramucirumab in Treating Patients With Metastatic or Locally Recurrent Gastric or Gastroesophageal Junction Cancer That Cannot Be Removed by Surgery

NCT03008278

Conditions
Digestive System Diseases, Digestive System Neoplasms, Esophageal Diseases, +21 more
Locations
  • City of Hope Corona Corona, California, United States
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • City of Hope Antelope Valley Lancaster, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
View all 32 locations
View Trial Details

Related conditions